New plant to push Duopharma to the fore of effervescent manufacturing
KUCHING: CCM Duopharma Biotech Bhd (Duopharma) expects its newly completed Effervescent plant in Bangi to put the company at the forefront of technology development in manufacturing high-quality pharmaceutical products using effervescent technology that offers advantages over conventional manufacturing of healthcare products.
The RM7 million effervescent plant – the country’s first ever such facility and commissioned in October 2017 – has the capability to produce 107 million tablets of Flavettes Effervescent Vitamin C annually.
Through the latest investment, Duopharma expects to roll out various effervescent products under the Company’s current range of award winning OTC brands, such as Flavettes, Champs, Proviton and Uphamol.
This range of products will provide consumers with a choice of a new delivery format for health supplements, which is seen to be a preferred trend in the market.
In November 2017, Duopharma launched four new Effervescent products under the Flavettes brand, and this range of Vitamin C products has been well accepted by the market, with an overwhelming demand.
Speaking at a media familiarisation trip to the plant, Duopharma group managing director Leonard Ariff Abdul Shatar said that Duopharma’s latest production facility is part of the Company’s Manufacturing Optimisation Strategy (MOS) which includes rationalising and upgrading its facilities to accelerate growth.
“There is a great demand for Effervescent pharmaceutical products, especially Flavettes Effervescent Vitamin C, in the market as they offer many functional benefits to consumers including providing a much easier way to ingest supplements instead of having to swallow a tablet, and giving a pleasant taste compared to regular tablets.
“As a leading pharmaceutical company in Malaysia, Duopharma strives to be at the vanguard of new technology as we constantly explore ways to enhance our customer experience.
“Formulating and manufacturing Effervescent products requires specialised knowledge and technological skill with an excellent environmental infrastructure to control the temperature and humidity of the production facility to ensure optimal product stability,” said Leonard Ariff.
Effervescent technology enables tablets to dissolve into a solution once they are in contact with water. This allows active ingredients to dissolve completely and evenly as well as to absorb quicker into the bloodstream compared to conventional formulations, resulting in faster onset of action.